Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

Moleculin Biotech ( ($MBRX) ) just unveiled an announcement. On December 9, 2025, Moleculin Biotech announced an update on its pivotal Phase 2B/3 ...

NDAA package revives stalled measures on US outbound investment and biotech, signalling Capitol Hill’s hardened stance ...

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector ...

Today we discuss why comparing U.S. vaccine policy to Europe’s is a red herring, why the revolving door at the FDA between ...

Partnering Platform Now Open for RegistrationSAN FRANCISCO--(BUSINESS WIRE)--#biotechshowcase--Biotech Showcase™ returns to ...

ASH's 2025 meeting ended with strong multiple myeloma data from J&J, a new treatment for a rare disorder, and strains on a ...

People come to Orlando to escape. With Disney World, SeaWorld and Universal Studios all in the area, there are endless ...

Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences ...

Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Read more at The ...

The US Congress is set to vote, could happen this week, on the 2025 National Defense Authorization Act (NDAA), a "must-pass" ...